Astal Laboratories Ltd

BSE : Macro_Intl.24 Jan 2025
Pharmaceuticals
₹
-0.45 (-0.53%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Astal Laboratories Ltd
Astal Laboratories Ltd
Pharmaceuticals
BSE : Macro_Intl.24 Jan 2025
₹
-0.45 (-0.53%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Astal Laboratories Ltd - Share Price & Details

Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
126.99%
Upper Circuit
Lower Circuit
P/E TTM
31.3
P/B Ratio
2.45
Traded Value(Cr)
0.00
EPS TTM
2.69
Book value
Dividend
0.00%

Invest in Astal Laboratories Ltd at ZERO Brokerage for 30 days

Price Performance

19.38 %
1 Wk
-0.06 %
1 M
3.30 %
3 M
126.99 %
1 Y
7.04 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Astal Laboratories Ltd
₹84.19(-0.45/-0.53%)
84.19-0.45148.51126.9931.302.45
Bliss GVS Pharma Ltd
₹161.95(-2.65/-1.61%)
161.95-2.651,706.4140.6421.111.67
Amrutanjan Health Care Ltd
₹693.15(-6.55/-0.94%)
693.15-6.552,003.9417.4942.166.73
Astrazeneca Pharma India Ltd
₹6,929.95(-143.25/-2.03%)
6,929.95-143.2517,324.888.17134.5925.50
Abbott India Ltd
₹27,272.70(-565.65/-2.03%)
27,272.70-565.6557,954.496.5245.1116.46
Ambalal Sarabhai Enterprises Ltd
₹49.26(-0.56/-1.12%)
49.26-0.56377.500.5542.838.38

About Astal Laboratories Ltd

Astal Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 148.51 crores. It has reported a sales of Rs. 13.16 crores and a net profit of Rs. 2 crores for the quarter ended December 2018. The company management includes , Sudheer Karna Kankanala,Hemachakrapani Bangaraiahgari,Ravikanti Shailaja,MAHENDRA KUMAR,P. Radha Kishore,MAGGIDI VENKATESH,Julius Paul Reinhard Paschke (Astal Laboratories Ltd) among others.
Chairman
Registered office
24/147 Ground Floor,Plaza Kalpana Birhana Road,Kanpur,Uttar Pradesh,208001
FAX :91-512-3042569
Background
Incorporation Year1993
Face Value₹10
Market Lot1

Latest News

Insurers are dropping HOAs, threatening the condo market

Insurance is getting harder to find and more expensive in much of the country. Just ask homeowners' associations. Mirroring trends in the single-family home market, insurers are boosting premiums or exiting the business of covering HOAs’ common property entirely, citing rising losses from extreme weather and aging buildings.
25 Jan 2025 | 09:56 PM

ICICI Bank will continue expansion within risk-return threshold, says ED

ICICI Bank’s Executive Director Sandeep Batra on January 25 said the bank will continue to grow their domestic corporate loan book within risk and rewards threshold. “Our focus has always been to grow within our risk and return thresholds while considering all available opportunities for serving our customers in a 360 degree manner,” Batra said during the post earnings conference call.
25 Jan 2025 | 09:54 PM

Sagar Cements Q3 Results 2025 on 25 Jan, 2025: loss falls by 2.72% YOY

Sagar Cements Q3 Results 2025: Sagar Cements reported a 68.6% year-over-year decline in topline and a loss of ₹55.07 crore in Q3 2025, with revenue growing 18.68% quarter-over-quarter. Earnings Per Share stood at ₹-4.17, while the company's market capitalization is ₹2789.82 crore with a Buy consensus recommendation from analysts.
25 Jan 2025 | 09:52 PM

Lmw Q3 Results 2025 on 25 Jan, 2025: profit falls by 80.46% YOY

Lmw Q3 Results 2025:On 25 January 2025, Lmw declared their Q3 results, revealing a significant decline in both revenue and profit. The topline decreased by 36.87% year-over-year, leading to a profit of  ₹19.3 crore, which marks an 80.46% drop compared to the same period last year. The revenue for the quarter stood at  ₹766.43 crore.
25 Jan 2025 | 09:51 PM

Aditya Birla Money Q3 Results 2025 on 25 Jan, 2025

Aditya Birla Money declared their Q3 results on 24 Jan, 2025. The topline increased by 2.93% year-over-year (YoY), with profit rising significantly by 43.96% YoY, amounting to ₹21.81 crore and revenue reaching ₹101.34 crore. However, when compared to the previous quarter, the company reported a decline in both revenue and profit, with revenue down by 10.18% and profit decreasing by 18.28%.
25 Jan 2025 | 09:50 PM
view more news

How to buy Astal Laboratories Ltd shares on nse?

To buy Astal Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Astal Laboratories Ltd share price today?

The Astal Laboratories Ltd shares price on nse is Rs.84.19 today.

What is the market cap of Astal Laboratories Ltd shares on BSE ?

The company has a market capitalization of Rs.148.51Cr

What is the PE & PB ratio of Astal Laboratories Ltd shares ?

PE is 31.3 and PB is 2.45

What is the 52 Week High and Low of Astal Laboratories Ltd shares?

Astal Laboratories Ltd stock price high: Rs.131.7 Astal Laboratories Ltd stock price low: Rs.37.09
BUY
SELL